Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Alligator Bioscience

0.01 SEK-9.01 %28/10 17:29
Less than 1K followers

ATORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-9.01 %
-54.30 %
-64.85 %
-92.90 %
-95.59 %
-96.00 %
-99.83 %
-99.95 %
-100.00 %

Alligator Bioscience is a research-based biotechnology company. The company uses a patented technology to develop biological drug candidates in inflammation and cancer, and is active in the earlier part of the drug development chain. Alligator Bioscience has a global technology platform and is active in the protein pharmaceutical segment. The company was founded in 2001 and is headquartered in Lund.

Read more
Market cap
36.04M SEK
Turnover
469.15K SEK
Revenue
510K
EBIT %
-20,750.2 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
27/11
2026

Extraordinary general meeting '26

11/2
2027

Annual report '26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-10-27 18:15

Kallelse till extra bolagsstämma i Alligator Bioscience AB

Alligator Bioscience
Regulatory press release2026-10-27 18:15

Notice of extraordinary general meeting in Alligator Bioscience AB

Alligator Bioscience
Regulatory press release2026-10-27 18:00

Styrelsen för Alligator Bioscience föreslår en sammanläggning av stamaktier

Alligator Bioscience

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-10-27 18:00

The Board of Directors of Alligator Bioscience proposes a reverse share split of ordinary shares

Alligator Bioscience
Regulatory press release2026-10-26 13:08

Finansinspektionen: Flaggningsmeddelande i Alligator Bioscience AB

Alligator Bioscience
Press release2026-10-23 14:21

Redeye: Alligator Bioscience (Q3 Review): Partnering Mitazalimab to Fund HLX22

Alligator Bioscience
Regulatory press release2026-10-22 08:00

Alligator Bioscience AB reports financial results for the period 1 January – 30 September 2026 and provides a business update

Alligator Bioscience
Regulatory press release2026-10-22 08:00

Alligator Bioscience AB presenterar finansiella resultat för perioden 1 januari – 30 september 2026 och ger en affärsuppdatering

Alligator Bioscience
Press release2026-10-15 14:00

Inbjudan till Alligator Biosciences rapportpresentation den 22 oktober 2026

Alligator Bioscience
Press release2026-10-15 14:00

Invitation to Alligator Bioscience’s interim report call on 22 October 2026

Alligator Bioscience
Regulatory press release2026-10-13 11:26

Finansinspektionen: Flaggningsmeddelande i Alligator Bioscience AB

Alligator Bioscience
Regulatory press release2026-10-12 16:29

Finansinspektionen: Flaggningsmeddelande i Alligator Bioscience AB

Alligator Bioscience
Press release2026-10-05 11:37

Redeye: Alligator Bioscience: CFO Johan Giléus to Take Over as CEO

Alligator Bioscience
Regulatory press release2026-10-04 15:45

Alligator Bioscience utser Johan Giléus till vd – Søren Bregenholt lämnar vid årsskiftet

Alligator Bioscience
Regulatory press release2026-10-04 15:45

Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end

Alligator Bioscience
Regulatory press release2026-09-29 11:45

Alligator Bioscience genomför en riktad emission av teckningsoptioner till Fenja Capital i samband med den genomförda företrädesemissionen

Alligator Bioscience
Regulatory press release2026-09-29 11:45

Alligator Bioscience carries out a directed issue of warrants to Fenja Capital in connection with the completed rights issue

Alligator Bioscience
Regulatory press release2026-09-22 16:30

Alligator Bioscience announces final outcome in rights issue

Alligator Bioscience
Regulatory press release2026-09-22 16:30

Alligator Bioscience offentliggör slutligt utfall i företrädesemission

Alligator Bioscience
Press release2026-09-21 16:56

Redeye: Alligator Bioscience: 17% Preliminary Subscription Rate

Alligator Bioscience